CELZ Stock Analysis: Buy, Sell, or Hold?
CELZ - Creative Medical Technology Holdings, Inc. Common Stock
$2.02
-0.09 (-4.27%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 13, 2026
Get Alerted When CELZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CELZ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CELZ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CELZ is currently trading at $2.02, which is considered fair relative to its 30-day fair value range of $1.91 to $2.23.
Technical Outlook: Technically, CELZ is in a downtrend. Immediate support is located at $1.91, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+890.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CELZ is in a downtrend. Immediate support is located at $1.91, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+890.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.91 -
$2.23
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 890.1% below Wall St target ($20.00)
Fair Price Analysis
30-Day Fair Range
$1.91 -
$2.23
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.91
Resistance Level
$2.30
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.44
Wall Street Target
$20.00
(+890.1%)
Earnings Growth (YoY)
358.9%
Last updated: January 31, 2026 9:32 PM ET
Data refreshes hourly during market hours. Next update: 10:32 PM
Data refreshes hourly during market hours. Next update: 10:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
Advanced CELZ Option Strategies
Professional options setups generated by AI based on today's CELZ price and gamma walls.
